Treatment with triamcinolone acetonide prevents decreased retinal levels of decorin in a rat model of oxygen-induced retinopathy

Current Eye Research

Volumn 35, Issue 7, 2010, Pages 657-663

  Park, Yeon Jeong ^a   Kim, Young Hee ^a   Choi, Wan Sung ^a   Chung, In Young ^a   Yoo, Ji Myong ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Decorin; Ganglion cells; Oxygen induced retinopathy; Retinal neurons; Triamcinolone acetonide

Indexed keywords

DECORIN; MESSENGER RNA; OXYGEN; TRIAMCINOLONE ACETONIDE; DCN PROTEIN, HUMAN; DCN PROTEIN, RAT; GLUCOCORTICOID; PROTEOGLYCAN; SCLEROPROTEIN;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VITREOUS BODY; WESTERN BLOTTING; ANIMAL; CELL DEATH; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; NEWBORN; PATHOLOGY; PREGNANCY; RETINA; RETINA GANGLION CELL; RETINOPATHY OF PREMATURITY; TOXICITY;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL DEATH; DECORIN; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPEROXIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFANT, NEWBORN; OXYGEN; PREGNANCY; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL GANGLION CELLS; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIAMCINOLONE ACETONIDE;

EID: 77954389763     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713681003760143     Document Type: Article

References (30)

1. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998;17:1-19. (Pubitemid 28206020)
2. Iozzo RV. Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem. 1998;67:609-652.
3. Rafael BE, Cláudio CW, Paulo ASM, et al. Major glycosamin-oglycan species in the developing retina: Synthesis, tissue distribution and effects upon cell death. Exp Eye Res. 2003;77:157-165.
4. Margolis RK, Margolis RU. Nervous tissue proteoglycans. Dev Neurosc. 1989;11:276-288.
5. Hartmann U, Maurer U. Proteoglycans in the nervous system\The quest for functional roles in vivo. Matrix Biol. 2001;20:23-35. (Pubitemid 32181344)
6. Lander AD. Understanding the molecules of neural cell contacts: Emerging patterns of structure and function. Trends Neurosci. 1989;12:189-195.
7. Maeda N, Oohira A. Proteoglycan and development of the brain: Functions of brain chondroitin sulfate proteoglycan. Trends Glycosci Glycotechnol. 1991;3:28-34. (Pubitemid 21902018)
8. Takahisa K, Masaru I, Akira H, et al. Expression of gly-cosaminoglycans during development of the rat retina. Curr Eye Res. 2003;27:75-83. (Pubitemid 37041191)
9. Kresse H, Hausser H, Schonherr E. Small proteoglycans. Experientia. 1993;49:403-416. (Pubitemid 23183836)
10. Border WA, Okuda S, Languino LR, et al. Transforming growth factor-ß regulates production of proteoglycans by mesangial cells. Kidney Int. 1990;37:689-695. (Pubitemid 20056841)
11. Mauviel A, Korang K, Santra M, et al. Identifcation of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene. J Biol Chem. 1996;271:24824-24829. (Pubitemid 26333232)
12. Masaru I, Hidenobu T, Megumi H, et al. Expression of pro-teoglycan decorin in neural retina. Invest Ophthalmol Vis Sci. 1999;40:1783-1791.
13. Brafman A, Mett I, Shafr M, et al. Inhibition of oxygen-induced retinopathy in RTP801-defcient mice. Invest Oph-thalmol Vis Sci. 2004;45:3796-3805. (Pubitemid 39298599)
14. Hammes HP, Lin J, Renner O, et al. Pericyte and the patho-genesis of diabetic retinopathy. Diabetes. 2002;51:3107-3112.
15. Ishihada S, Usui T, Yamashiro K, et al. VEGF 164-mediated infammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J Exp Med. 2003;198:483-489.
16. Downie LE, Pianta MJ, Vingrys AJ, et al. Neuronal and glial cell changes are determined by retinal vascularization in retin-opathy of prematurity. J Comp Neurol. 2007;504:404-417.
17. Kim YH, Chung IY, Choi MY, et al. Triamcinolone suppress retinal vascular pathology via a potent interruption of proinfammatory signal-regulated activation of VEGF during a relative hypoxia. Neurobiol Dis. 2007;26:569-576.
18. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcino-lone acetonide for treatment of intraocular proliferative, exudative, and neovascular disease. Prog Retinal Eye Res. 2005;24:587-611. (Pubitemid 40949559)
19. Ozdek SC, Aydin B, Gurelik G, et al. Effects of intravitreal triamcinolone acetonide injection on macular edema and visual prognosis in central retinal vein occlusion. Int Oph-thalmol. 2006;16:27-34.
20. Psarra AG, Bochaton-Piallat M-L, Gabbiani G, et al. Mito-chondrial localization of glucocorticoid receptor in glial (Muller) cells in the salamander retina. Glia. 2003;41:38-49. (Pubitemid 36164283)
21. Wenzel A, Grimm C, Seeliger MW, et al. Prevention of pho-toreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42:1653-1659. (Pubitemid 32520761)
22. Abraham IM, Harkany T, Horvath KM, et al. Action of glucocorticoids on survival of nerve cells: Promoting neurodegeneration or neuroprotection? J Neuroendocrinol. 2001;13:749-760. (Pubitemid 32894429)
23. Robert BB, Bryan JW, On-Tat L, et al. Neuroprotective effect of intravitreal triamcinolone acetonide against photorecep-tor apoptosis in a rabbit model of subretinal hemorrhage. Invest Ophthalmol Vis Sci. 2008;49:4071-4077.
24. Toth CA, Benner JD, Hjelmeland LM, et al. Ultramicrosurgi-cal removal of subretinal hemorrhage in cats. Am J Ophthal-mol. 1992;113:175-182.
25. Kim YH, Kim YS, Kang SS, et al. Expression of 14-3-3-ζ and interaction with protein kinase C in the rat in early diabetes. Diabetologia. 2005;48:1411-1415. (Pubitemid 41186109)
26. Tanihara H, Inatani M, Koga T, et al. Proteoglycans in the eye. Cornea. 2002;21(Suppl 7):S62-S69.
27. Janell MJ, Terri LY, Jody ASR. Small leucine rich repeat pro-teoglycans (SLRPs) in the human sclera: Identifcation of abundant levels of PRELP. Mol Vis. 2006;12:1057-1066.
28. Zhang G, Chen S, Goldoni S, et al. Genetic evidence for the cooridinated regulation of collagen fbrillogenesis in the cornea by decorin and biglycan. J Biol Chem. 2009;13:8888-8897.
29. Chia-Hsin C, John VM, Mao-Hsiung H, et al. Mechanical strain promotes fbroblast gene expression in presence of corticosteroid. Conn Tis Res. 2007;48:65-69.
30. Richardson DW, Dodge GR. Dose-dependent effects of corti-costeroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Infamm Res. 2003;52:39-49.